Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Current guideline recommendations and analysis of evidence quality on low-intensity shockwave therapy for erectile dysfunction

Abstract

Erectile dysfunction (ED) is defined as the inability to attain and maintain erection of the penis sufficient to permit satisfactory sexual activity. ED most commonly affects men from 40 years of age with a clear age-associated increase in prevalence. The condition may have significant negative impact on quality of life for both the patients and their partners. Over recent years, low-intensity shockwave therapy (LIST) has gained popularity in the treatment of ED, based on the assumption that LIST application may result in neoangiogenesis and thus increased blood flow to the corpora cavernosa. The increasing usage of LIST is contrasting with current guidelines, with the EAU guideline on ED stating that LIST can be used in mild organic ED patients or poor responders to PDE5I’s, but with a weak strength of recommendation. In the AUA guideline on ED, the panel makes a conditional recommendation of grade C that LIST should be considered investigational. In this review, we will briefly review practice patterns, and critically discuss the evidence based on which these guideline statements have been made.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    NIH Consensus Conference. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993. https://doi.org/10.1001/jama.1993.03510010089036.Text

  2. 2.

    Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000;12:305–11.

    CAS  Article  Google Scholar 

  3. 3.

    Philippou YA, Jung JH, Steggall MJ, O'Driscoll ST, Bakker CJ, Bodie JA, Dahm P. Penile rehabilitation for postprostatectomy erectile dysfunction. Cochrane Database Syst Rev. 2018;10:CD012414.

  4. 4.

    Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A, Schulman C, et al. Torres LO. Endocrine aspects of male sexual dysfunctions. J Sex Med. 2010;7:1627–56

    Article  Google Scholar 

  5. 5.

    Jackson G, Montorsi P, Adams MA, Anis T, El-Sakka A, Miner M, et al. Cardiovascular aspects of sexual medicine. 2010;7:1608–26. https://doi.org/10.1111/j.1743-6109.2010.01779.x.

    Article  Google Scholar 

  6. 6.

    Deveci S, Palese M, Parker M, Guhring P, Mulhall JP. Erectile function profiles in men with Peyronie's disease. J Urol. 2006;175:1807–11

    Article  Google Scholar 

  7. 7.

    Besiroglu H, Otunctemur A, Ozbek E. The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med. 2015;12:1309–18. https://doi.org/10.1111/jsm.12885

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Shiri R, Koskimäki J, Häkkinen J, et al. Effects of age, comorbidity and lifestyle factors on erectile function: Tampere Ageing Male Urological Study (TAMUS). Eur Urol. 2004;45:628–33. https://doi.org/10.1016/j.eururo.2003.11.020

    Article  PubMed  Google Scholar 

  9. 9.

    Sánchez-Cruz JJ, Cabrera-León A, Martín-Morales A, Fernández A, Burgos R, Rejas J. Male erectile dysfunction and health-related quality of life. Eur Urol. 2003;44:245–53. https://doi.org/10.1038/nrd893

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Rotella DP. Phosphodiesterase 5 inhibitors: current status and potential applications. Nat Rev Drug Discov. 2002;1:674–82.

    CAS  Article  Google Scholar 

  11. 11.

    Carson CC, Burnett AL, Levine LA, Nehra A. The efficacy of sildenafil citrate (viagra®) in clinical populations: an update. Urology . 2002;60:12–27.

    Article  Google Scholar 

  12. 12.

    Hatzimouratidis K, Hatzichristou DG. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs. 2005;65:1621–50.

    CAS  Article  Google Scholar 

  13. 13.

    Montorsi F, Verheyden B, Meuleman E, et al. Long-term safety and tolerability of Tadalafil in the treatment of erectile dysfunction. Eur Urol. 2004;45:339–45. https://doi.org/10.1016/j.eururo.2003.11.010

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Corona G, Mondaini N, Ungar A, Razzoli E, Rossi A, Fusco F. Phosphodiesterase Type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient. J Sex Med. 2011;8:3418–32. https://doi.org/10.1111/j.1743-6109.2011.02473.x

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57:804–14. https://doi.org/10.1016/j.eururo.2010.02.020

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Hanson-Divers C, Jackson SE, Lue TF, Crawford SY, Rosen RC. Health outcomes variables important to patients in the treatment of erectile dysfunction. J Urol. 1998;159:1541–7.

    CAS  Article  Google Scholar 

  17. 17.

    Fode M, Hatzichristodoulou G, Serefoglu EC, Verze P, Albersen M. Low-intensity shockwave therapy for erectile dysfunction: Is the evidence strong enough? Nat Rev Urol. 2017;14:593–606. https://doi.org/10.1038/nrurol.2017.119

    CAS  Article  Google Scholar 

  18. 18.

    Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010;58:243–8. https://doi.org/10.1016/j.eururo.2010.04.004

    Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Cleveland RO, McAteer JA. Physics of shock-wave lithotripsy. In: Smith’s textbook of endourology Smith's Textbook of Endourology, I&II, 3rd Edition (Arthur D. Smith MD, Gopal H. Badlani MD, Glenn M. Preminger MD, Louis R. Kavoussi MD (eds.)) Blackwell Publishing Ltd, 2012. p. 527–58.

  20. 20.

    Seidl M, Steinbach P, Wörle K, Hofstädter F. Induction of stress fibres and intercellular gaps in human vascular endothelium by shock-waves. Ultrasonics. 1994;32:397–400. https://doi.org/10.1016/j.eururo.2010.04.004

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Apfel R. Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br J Cancer Suppl. 1982;5:140–6.

  22. 22.

    Ciampa AR, De Prati AC, Amelio E, et al. Nitric oxide mediates anti-inflammatory action of extracorporeal shock waves. FEBS Lett. 2005;579:6839–45. https://doi.org/10.1016/j.febslet.2005.11.023

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Gotte G, Amelio E, Russo S, Marlinghaus E, Musci G, Suzuki H. Short-time non-enzymatic nitric oxide synthesis from L-arginine and hydrogen peroxide induced by shock waves treatment. FEBS Lett. 2002;520:153–5. https://doi.org/10.1016/S0014-5793(02)02807-7

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy—a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. J Sex Med. 2012;9:259–64. https://doi.org/10.1111/j.1743-6109.2011.02498.x

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Bechara A, Casabé A, De Bonis W, Ciciclia PG. Twelve-month efficacy and safety of low-intensity shockwave therapy for erectile dysfunction in patients who do not respond to phosphodiesterase type 5 inhibitors. Sex Med. 2016;4:e225–e232. https://doi.org/10.1016/j.esxm.2016.06.001

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Tsai CC, Wang CJ, Lee YC, et al. Low-intensity extracorporeal shockwave therapy can improve erectile function in patients who failed to respond to phosphodiesterase type 5 inhibitors. Am J Mens Health. 2017;11:1781–90. https://doi.org/10.1177/1557988317721643

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Kitrey ND, Gruenwald I, Appel B, Shechter A, Massarwa O, Vardi Y. Penile low intensity shock wave treatment is able to shift PDE5i nonresponders to responders: a double-blind, sham controlled study. J Urol. 2016;195:1550–5. https://doi.org/10.1016/j.juro.2015.12.049

    Article  Google Scholar 

  28. 28.

    Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633–41. https://doi.org/10.1016/j.juro.2018.05.004

    Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Kalyvianakis D, Memmos E, Mykoniatis I, Kapoteli P, Memmos D, Hatzichristou D. Low-intensity shockwave therapy for erectile dysfunction: a randomized clinical trial comparing 2 treatment protocols and the impact of repeating treatment. J Sex Med. 2018:1–12. https://doi.org/10.1016/j.jsxm.2018.01.003

    Article  Google Scholar 

  30. 30.

    Reisman Y, Hind A, Varaneckas A, Motil I. Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study. Int J Impot Res. 2014;27:108–12. https://doi.org/10.1038/ijir.2014.41

    Article  PubMed  Google Scholar 

  31. 31.

    Pelayo-Nieto M, Linden-Castro E, Alias-Melgar A, et al. Linear shock wave therapy in the treatment of erectile dysfunction. Actas Urol Esp. 2015;39:456–9. https://doi.org/10.1016/j.acuro.2014.09.010

    CAS  Article  Google Scholar 

  32. 32.

    Hisasue S, China T, Horiuchi A, et al. Impact of aging and comorbidity on the efficacy of low-intensity shock wave therapy for erectile dysfunction. Int J Urol. 2016;23:80–4. https://doi.org/10.1111/iju.12955

    Article  Google Scholar 

  33. 33.

    Chung E, Cartmill R. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial. BJU Int. 2015;115(S5):46–9. https://doi.org/10.1111/bju.13035

    Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Ruffo A, Capece M, Prezioso D, et al. Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction. Int Braz J Urol. 2015;41:967–74. https://doi.org/10.1590/S1677-5538.IBJU.2014.0386

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Frey A, Sønksen J, Fode M. Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study. Scand J Urol. 2016;50:123–7. https://doi.org/10.3109/21681805.2015.1100675

    Article  Google Scholar 

  36. 36.

    Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the international index of erectile function scale. Eur Urol. 2011;60:1010–6. https://doi.org/10.1016/j.eururo.2011.07.053

    Article  Google Scholar 

  37. 37.

    Katz JE, Molina ML, Clavijo R, Prakash NS, Ramasamy R. A phase 2 randomized trial to evaluate different dose regimens of low-intensity extracorporeal shockwave therapy for erectile dysfunction: clinical trial update. Eur Urol Focus. 2018;4:336–7. https://doi.org/10.1016/j.euf.2018.07.011

    Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Kitrey ND, Vardi Y, Appel B, et al. Low intensity shock wave treatment for erectile dysfunction—how long does the effect last? J Urol. 2018;200:167–70. https://doi.org/10.1016/j.juro.2018.02.070

    Article  Google Scholar 

  39. 39.

    Mulhall JP, Carlsson M, Stecher V, Tseng LJ. Predictors of erectile function normalization in men with erectile dysfunction treated with placebo. J Sex Med. 2018;15:866–72. https://doi.org/10.1016/j.jsxm.2018.03.089

    Article  PubMed  Google Scholar 

  40. 40.

    de Araujo AC, da Silva FG, Salvi F, Awad MC, da Silva EA, Damião R. The management of erectile dysfunction with placebo only: does it work? J Sex Med. 2009;6. https://www.jsm.jsexmed.org/article/S1743-6095(15)32350-X/fulltext.

  41. 41.

    Fojecki GL, Tiessen S, Osther PJS. Effect of low-energy linear shockwave therapy on erectile dysfunction—a double-blinded, sham-controlled, randomized clinical trial. J Sex Med. 2016;14:106–12. https://doi.org/10.1016/j.jsxm.2016.11.307

    Article  PubMed  Google Scholar 

  42. 42.

    Fojecki GL, Tiessen S, Sloth Osther PJ. Effect of linear low-intensity extracorporeal shockwave therapy for erectile dysfunction-12-month follow-up of a randomized, double-blinded, sham-controlled study. Sex Med. 2018;6:1–7. https://doi.org/10.1016/j.esxm.2017.09.002

    Article  Google Scholar 

  43. 43.

    Yee C-H, Chan ES, Hou SS-M, Ng C-F. Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study. Int J Urol. 2014;21:1041–5. https://doi.org/10.1111/iju.12506

    Article  PubMed  PubMed Central  Google Scholar 

  44. 44.

    Olsen AB, Persiani M, Boie S, Hanna M, Lund L. Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study. Scand J Urol. 2015;49:329–33. https://doi.org/10.3109/21681805.2014.984326

    Article  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Motil I, Kubis I, Sramkova T. Treatment of vasculogenic erectile dysfunction with Piezowave 2 device. Application of low intensity shockwaves using novel linear shockwave tissue coverage (LSTC-ED®) technique. A prospective, multicentric, placebo-controlled study. Adv Sex Med. 2016;6:15–8.

  46. 46.

    Srini VS, Reddy RK, Shultz T, Denes B. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population. Can J Urol. 2015;22:7614–22.

    Google Scholar 

  47. 47.

    Yamaçake KGR, Carneiro F, Cury J, Lourenço R, Françolin PC, Piovesan AC, et al. Low-intensity shockwave therapy for erectile dysfunction in kidney transplant recipients. A prospective, randomized, double blinded, sham-controlled study with evaluation by penile Doppler ultrasonography. Int J Impot Res. 2018. https://doi.org/10.1038/s41443-018-0062-2

  48. 48.

    Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol. 2012;187:1769–75. https://doi.org/10.1016/j.juro.2011.12.117

    Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Kalyvianakis D, Hatzichristou D. Low-intensity shockwave therapy improves hemodynamic parameters in patients with vasculogenic erectile dysfunction: a triplex ultrasonography-based sham-controlled trial. J Sex Med. 2017;14:891–7. https://doi.org/10.1016/j.jsxm.2017.05.012

    Article  PubMed  PubMed Central  Google Scholar 

  50. 50.

    Zewin TS, El A, Ahmed A, et al. Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial. Int Urol Nephrol. 2018;50:2007–14. https://doi.org/10.1007/s11255-018-1987-6

    CAS  Article  PubMed  Google Scholar 

  51. 51.

    Lu Z, Lin G, Reed-Maldonado A, Wang C, Lee YC, Lue TF. Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis. Eur Urol. 2017;71:223–33. https://doi.org/10.1016/j.eururo.2016.05.050

    Article  PubMed  PubMed Central  Google Scholar 

  52. 52.

    Man L, Li G. Low-intensity extracorporeal shock wave therapy for erectile dysfunction: a systematic review and meta-analysis. Amsterdam: Elsevier Inc.; 2017.

  53. 53.

    Clavijo RI, Kohn TP, Kohn JR, Ramasamy R. Effects of low-intensity extracorporeal shockwave therapy on erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2016;14:27–35. https://doi.org/10.1016/j.jsxm.2016.11.001

    Article  PubMed  Google Scholar 

  54. 54.

    Zou Z, Tang L, Liu Z, et al. Short-term efficacy and safety of low-intensity extracorporeal shock wave therapy in erectile dysfunction: a systematic review and meta-analysis. Int Braz J Urol. 2017;43:805–21. https://doi.org/10.1590/s1677-5538.ibju.2016.0245

    Article  PubMed  PubMed Central  Google Scholar 

  55. 55.

    Angulo J, Arancea B, Heras, et al. Efficacy of low-intensity shock wave therapy for erectile dysfunction: a systematic review and meta-analysis. Actas Urol Esp. 2017;41:479–90.

    CAS  Article  Google Scholar 

  56. 56.

    Feldman R, Denes B, Appel B, Vasan SS, Shultz T, Burnett A. Pd45-10 the safety and efficacy of Li-Eswt in 604 patients for erectile dysfunction: summary of current and evolving evidence. J Urol. 2015;193:e905–e906. https://doi.org/10.1016/j.juro.2015.02.2582

    Article  Google Scholar 

  57. 57.

    Rizk PJ, Krieger JR, Kohn TP, Pastuszak AW. Low-intensity shockwave therapy for erectile dysfunction. Sex Med Rev. 2018:1–7. https://doi.org/10.1016/j.sxmr.2018.01.002

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Maarten Albersen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Schoofs, E., Fode, M., Capogrosso, P. et al. Current guideline recommendations and analysis of evidence quality on low-intensity shockwave therapy for erectile dysfunction. Int J Impot Res 31, 209–217 (2019). https://doi.org/10.1038/s41443-019-0132-0

Download citation

Further reading

Search

Quick links